The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice

Brain Research

Volumn 741, Issue 1-2, 1996, Pages 215-219

  Dluzen, Dean E ^a   Kefalas, George ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

dopamine; locus coeruleus; neurotoxicity; nigrostriatal; norepinephrine; transporter; uptake

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; LOCUS CERULEUS; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADMINISTRATION, INTRANASAL; ANIMALS; CATECHOLAMINES; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; OLFACTORY BULB;

EID: 0030601978     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00934-1     Document Type: Article

References (29)

1. [1] Ali, S.F., David, S.N., Newport, G.D., Cadet, J.L. and Slikker, W., Jr., MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels, Synapse, 18 (1994) 27-34.
2. [2] Baker, H. and Spencer, R.F., Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WG-HRP) from the olfactory epithelium to the brain of the adult rat, Exp. Brain Res., 63 (1986) 461-473.
3. [3] Barnett, E.M. and Perlman, S., The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM, Virology, 194 (1993) 185-191.
4. [4] Brittebo, E.B., Metabolism of xenobiotics in the nasal olfactory mucosa: implications for local toxicity, Pharmacol. Toxicol., 72 (Suppl. 3) (1993) 50-52.
5. [5] Calne, D.B., McGreer, E., Eisen, A. and Spencer, P., Alzheimer's disease, Parkinson's disease and motoneurone disease: abiotrophic interaction between aging and the environment? Lancet, 2 (1986) 1067-1070.
6. [6] Date, I., Felten, D.L. and Felten, S.Y., Long term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis, Brain Res., 519 (1990) 266-276.
7. [7] Dluzen, D.E., 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces norepinephrine concentrations in the olfactory bulbs of male mice, Brain Res., 586 (1992) 144-147.
8. [8] Dluzen, D.E. and Kreutzberg, J.D., 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse, Brain Res., 609 (1993) 98-102.
9. [9] Gerlach, M., Riederer, P., Przuntek, H. and Youdim, M.B.H., MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease, Eur. J. Pharmacol., 208 (1991) 273-286.
10. [10] Giovanni, A., Sieber, B.-A., Heikkila, R.E. and Sonsalla, P.K., Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: systemic administration, J. Pharmacol. Exp. Ther., 270 (1994) 1000-1007.
11. [11] Gupta, M., Gupta, B.K., Thomas, R., Bruemmer, V., Sladek J.R., Jr. and Felten, D.L., Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults, Neurosci. Lett., 70 (1986) 326-331.
12. [12] Hastings, L. and Evans, J.E., Olfactory primary neurons as a route of entry for toxic agents into the CNS, Neurotoxicology, 12 (1991) 707-714.
13. [13] Hu, S.C., Chang, F.W., Sung, Y.J., Hsu, W.M. and Lee, E.H.Y., Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and locus coeruleus in BALB/c mice, J. Pharmacol. Exp. Ther., 259 (1991) 1379-1387.
14. [14] Janson, A.M., The mouse MPTP model of Parkinson's disease, Neurosci. Facts (Fidia Research Foundation), 3 (1992) 89-90.
15. [15] Jossan, S.S., Sakurai, E. and Oreland, L., MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species, Pharmacol. Toxicol., 64 (1989) 314-318.
16. [16] Kawano, T. and Margolis, F.L., Transynaptic regulation of olfactory bulb catecholamines in mice and rats, J. Neurochem., 39 (1982) 342-348.
17. [17] Kern, W., Pietrowsky, R., Born, J. and Fehm, H.L., Evidence for central nervous effects of insulin on sensory processing in man. In Proc. Int. Soc. Psychoneuroendocr., 26th Congr., Abstract 1-23, 1995, p. 22.
18. [18] Langston, J.W. and Young, A., Neurotoxins and neurodegenerative diseases, Ann. NY Acad. Sci., 648 (1992) 1-385.
19. [19] Leopold, D.A., Nasal toxicity: end points of concern in humans, Inhalation Toxicol., 6 (Suppl.) (1994) 23-29.
20. [20] Mayer, R.A., Kindt, M.V. and Heikkila, R.E., Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethlamine transport, J. Neurochem., 47 (1986) 1073-1079.
21. [21] McLean, J.H., Shipley, M.T., Nickell, W.T., Aston, J.G. and Reyher, C.K., Chemoanatomical organization of the noradrenergic input from locus coeruleus to the olfactory bulb of the adult rat, J. Comp. Neurol., 285 (1989) 339-349.
22. [22] O'Donohue, T.L., Crowley, W.R. and Jacobowitz, D.M., Biochemical mapping of the noradrenergic ventral bundle projection sites: evidence for a noradrenergic-dopaminergic interaction, Brain Res., 172 (1979) 87-100.
23. [23] Roberts, E., Alzheimer's disease may begin in the nose and be caused by aluminosilicates, Neurobiol. Aging, 7 (1986) 561-590.
24. [24] Shipley, M.T., Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium, Brain Res. Bull., 15 (1985) 129-142.
25. [25] Shipley, M.T., Halloran, F.J. and De La Torre, J., Surprisingly rich projections from locus coeruleus to the olfactory bulb in the rat, Brain Res., 329 (1985) 294-299.
26. [26] Speciale, S.G., Crowley, W.R., O'Donohue, T.L. and Jacobowitz, D.M., Forebrain catecholamine projections of the A5 cell group, Brain Res., 154 (1978) 128-133.
27. [27] Sziraki, I., Kardos, V., Patthy, M., Patfalusi, M. and Budai, G., Methamphetamine protects against MPTP neurotoxicity in C57BL mice, Eur. J. Pharmacol., 251 (1994) 311-314.
28. [28] Young, J.K., Alzheimer's disease and metal containing glia, Med. Hypotheses, 38 (1992) 1-4.
29. [29] Zatta, P., Favarato, M. and Nicolini, M., Deposition of aluminum in brain tissues of rats exposed to inhalation of aluminum acetylacetonate, NeuroReport, 4 (1993) 1119-1122.